[1]郭宇婧,李宏娟,张嘉曦,等.高迁移率蛋白1的小干扰RNA对高糖环境下视网膜血管内皮细胞凋亡的影响[J].眼科新进展,2018,38(5):416-420.[doi:10.13389/j.cnki.rao.2018.0097]
　GUO Yu-Jing,LI Hong-Juan,ZHANG Jia-Xi,et al.Effects of HMGB1 siRNA on the apoptosis of retinal vascular endothelial cells in high glucose environment[J].Recent Advances in Ophthalmology,2018,38(5):416-420.[doi:10.13389/j.cnki.rao.2018.0097]
点击复制

高迁移率蛋白1的小干扰RNA对高糖环境下视网膜血管内皮细胞凋亡的影响/HTML
分享到：

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
38卷
期数:
2018年5期
页码:
416-420
栏目:
实验研究
出版日期:
2018-05-05

文章信息/Info

Title:
Effects of HMGB1 siRNA on the apoptosis of retinal vascular endothelial cells in high glucose environment
作者:
郭宇婧; 李宏娟; 张嘉曦; 付舒; 姜双
121000　辽宁省锦州市，锦州医科大学（郭宇婧，李宏娟，张嘉曦，付舒）；121000　辽宁省锦州市，锦州医科大学附属第三医院（姜双）
Author(s):
GUO Yu-Jing; LI Hong-Juan; ZHANG Jia-Xi; FU Shu; JIANG Shuang
Jinzhou Medical University（GUO Yu-Jing，LI Hong-Juan，ZHANG Jia-Xi，FU Shu），Jinzhou 121000，Liaoning Province，China；Department of Ophthalmology，the Third Affiliated Hospital，Jinzhou MedicalUniversity（JIANG Shuang），Jinzhou 121000，Liaoning Province，China
关键词:
糖尿病视网膜病变; 高迁移率蛋白1; 小干扰RNA; 凋亡; 视网膜血管内皮细胞
Keywords:
diabetic retinopathy; high mobility protein 1; small interfering RNA; apoptosis; retinal vascular endothelial cells
分类号:
R774.1
DOI:
10.13389/j.cnki.rao.2018.0097
文献标志码:
A
摘要:
目的　探讨高迁移率蛋白1（high-mobility group box-1，HMGB1）的小干扰RNA（small interfering RNA，siRNA）对视网膜血管内皮细胞的影响。方法　采用siRNA对HMGB1的表达进行抑制，采用CCK8检测试剂盒、Hochest33342染色、流式细胞仪检测，观察高糖环境下HMGB1 siRNA对视网膜血管内皮细胞的影响，同时通过Western blot检测凋亡相关蛋白的表达。结果　HMGB1转染后，siRNA组的蛋白表达与正常对照组相比减少了73%（P<0.05），siRNA组的蛋白表达与非特异性siRNA（scr-siRNA）组相比减少了75%（P<0.05），而正常对照组和scr-siRNA组之间差异无统计学意义（P>0.05）。流式细胞仪检测结果显示，正常对照组、高糖组、scr-siRNA组和siRNA组细胞的总凋亡率分别为（0.40±0.03）%、（49.80±3.50）%、（47.60±1.98）%和（23.60±2.40）%。与正常对照组相比，高糖组、scr-siRNA组、siRNA组的细胞凋亡率均明显升高（均为P<0.05）；与scr-siRNA组相比，siRNA组的细胞凋亡率明显降低，差异有统计学意义（P<0.05）；而scr-siRNA组和高糖组的细胞凋亡率差异无统计学意义（P>0.05）。与正常对照组相比，高糖组和scr-siRNA组的cleaved-caspase 3蛋白（半胱天冬酶3）表达分别增加了（233±10）%、（266±22）%（均为P<0.05）；与scr-siRNA组相比，siRNA组的cleaved-caspase 3蛋白表达减少了（43±3）%（P<0.05）；而高糖组和scr-siRNA组的蛋白表达差异无统计学意义（P>0.05）。与正常对照组相比，高糖组和scr-siRNA组的B淋巴细胞瘤-2（B-cell lymphoma-2，Bcl-2）蛋白表达分别减少了（32±2）%、（29±3）%（均为P<0.05）；与scr-siRNA组相比，siRNA组的Bcl-2蛋白表达增加了（42±2）%（P<0.05）；而高糖组和scr-siRNA组的蛋白表达差异无统计学意义（P>0.05）。结论　HMGB1 siRNA可以通过抑制cleaved-caspase 3的活化和增加Bcl-2蛋白的表达减轻高糖环境下视网膜血管内皮细胞的凋亡。
Abstract:
Objective　To investigate the effects of HMGB1 small interference RNA （siRNA） on retinal vascular endothelial cells.Methods　siRNA was used to inhibit the expression of HMGB1，followed by the application of CCK8 assay，Hochest33342 staining and flow cytometry to observe the effects of HMGB1 siRNA on retinal vascular endothelial cells in high glucose environment.Meanwhile，the expression of proteins related to apoptosis was detected by Western blot.Results　The transfection of HMGB1 siRNA down-regulated the protein expression level of HMGB1 by 73% in siRNA group compared with normal control （NC） group （P<0.05），and the protein expression level of HMGB1 in siRNA group was decreased by 75% compared with scr-siRNA group （P<0.05）.There was no significant difference between NC group and scr-siRNA group （P>0.05）.The total apoptotic rate of NC group，high-glucose group，scr-siRNA group and siRNA group was （0.40±0.03）%，（49.80±3.50）%，（47.60±1.98）% and （23.60±2.40）% by flow cytometry.Compared with NC group，the apoptotic rates of high-glucose group，scr-siRNA group and siRNA group were increased （all P<0.05）.Compared with scr-siRNA group，the apoptotic rate of HRECs in siRNA group was reduced，with significant statistical difference （P<0.05）.There was no significant difference in the rate of cell apoptosis between scr-siRNA group and high-glucose group （P>0.05）.Compared with the NC group，the protein expression level of cleaved-caspase3 protein in high-glucose group and scr-siRNA group were increased by （233±10）% and （266±22）%，respectively （both P<0.05）；compared with scr-siRNA group，the protein expression level of cleaved-caspase 3 in siRNA group was reduced by （43±3）% （P<0.05）；and there was no significant difference in the protein expression of cleaved-caspase 3 in high-glucose group and scr-siRNA group （P>0.05）.Compared with the NC group，the protein expression of B-cell lymphoma-2 （Bcl-2） in high-glucose group and scr-siRNA group was decreased by （32±2）% and （29±3）%，accordingly （both P<0.05）；compared with scr-siRNA group，the protein expression level of Bcl-2 in siRNA group was increased by （42±2）%（P<0.05）；and there was no significant difference in the protein expression of Bcl-2 in high-glucose group and scr-siRNA group （P>0.05）.Conclusion　HMGB1 siRNA can reduce the apoptosis of retinal vascular endothelial cells in high glucose environment by inhibiting the activation of cleaved-caspase3 and increasing the expression of Bcl-2.

参考文献/References:

［1］　HWAIZ R，HASAN Z，RAHMAN M，ZHANG S，PALANI K，SYK I，et al.Rac1 signaling regulates sepsis-induced pathologic inflammation in the lung via attenuation of Mac-1 expression and CXC chemokine formation［J］.J Surg Res，2013，183（2）：798-807.
［2］　OMBRELLINO M，WANG H，AJEMIAN MS，TALHOUK A，SCHER LA，FRIEDMAN SG，et al.Increased serum concentrations of high-mobility-group protein 1 in haemorrhagic shock［J］.Lancet，1999，354（9188）：1446-1447.
［3］　TSUNG A，TOHME S，BILLIAR TR.High-mobility group box-1 in sterile inflammation［J］.J Intern Med，2014，276（5）：425-443.
［4］　HUEBENER P，HERNANDEZ C，SCHWABE RF.HMGB1 and injury amplification［J］.Oncotarget，2015，6（27）：23048-23049.
［5］　JIANG S，CHEN X.Expression of high-mobility group box 1 protein （HMGB1） and toll-like receptor 9 （TLR9） in retinas of diabetic rats［J］.Med Sci Monit，2017，23：3115-3122.
［6］　JIANG S，CHEN X.HMGB1 siRNA can reduce damage to retinal cells induced by high glucose in vitro and in vivo［J］.Drug Des Devel Ther，2017，11：783-795.
［7］　SHIN ES，SORENSON CM，SHEIBANI N.Diabetes and retinal vascular dysfunction［J］.J Ophthalmic Vis Res，2014，9（3）：362-373.
［8］　RASK-MADSEN C，KING GL.Vascular complications of diabetes：mechanisms of injury and protective factors［J］.Cell Metab，2013，17（1）：20-33.
［9］　YU Y，YANG L，LV J，HUANG X，YI J，PEI C，et al.The role of high mobility group box 1 （HMGB-1） in the diabetic retinopathy inflammation and apoptosis［J］.Int J Clin Exp Pathol，2015，8（6）：6807-6813.
［10］　ABU EAM，NAWAZ MI，KANGAVE D，ABOUAMMOH M，MOHAMMAD G.High-mobility group box-1 and endothelial cell angiogenic markers in the vitreous from patients with proliferative diabetic retinopathy［J］.Mediators Inflamm，2012，2012：697489.
［11］　YANG S，XU L，YANG T，WANG F.High-mobility group box-1 and its role in angiogenesis［J］.J Leukoc Biol，2014，95（4）：563-574.
［12］　MOHAMMAD G，SIDDIQUEI MM，OTHMAN A，AL-SHABRAW-EY M，ABU EAM.High-mobility group box-1 protein activates inflammatory signaling pathway components and disrupts retinal vascular-barrier in the diabetic retina［J］.Exp Eye Res，2013，107：101-109.
［13］　ABU EAM，MOHAMMAD G，NAWAZ MI，SIDDIQUEI MM.High-mobility group box-1 modulates the expression of inflammatory and angiogenic signaling pathways in diabetic retina［J］.Curr Eye Res，2015，40（11）：1141-1152.
［14］　ZHAO H，ZHANG J，YU J.HMGB-1 as a potential target for the treatment of diabetic retinopathy［J］.Med Sci Monit，2015，21：3062-3067.
［15］　HANRAHAN F，HUMPHRIES P，CAMPBELL M.RNAi-mediated barrier modulation：synergies of the brain and eye［J］.Ther Deliv，2010，1（4）：587-594.
［16］　ZHANG YF，WEI W，LI L，TU G，ZHANG Y.Sirt1 and HMGB1 regulate the AGE-induced pro-inflammatory cytokines in human retinal cells［J］.Clin Lab，2015，61（8）：999-1008.
［17］　CHEN XL，ZHANG XD，LI YY，CHEN XM，TANG DR，RAN RJ.Involvement of HMGB1 mediated signalling pathway in diabetic retinopathy：evidence from type 2 diabetic rats and ARPE-19 cells under diabetic condition［J］.Br J Ophthalmol，2013，97（12）：1598-1603.
［18］　AGARWAL A，SOLIMAN MK，SEPAH YJ，DO DV，NGUYEN QD.Diabetic retinopathy：variations in patient therapeutic outcomes and pharmacogenomics［J］.Pharmgenomics Pers Med，2014，7：399-409.

相似文献/References:

[1]杜玮 刘子扬 周艳艳 雒雷鸣.糖尿病视网膜病变与血清胆红素水平的关系[J].眼科新进展,2012,32(5):000.
[2]范松涛 卢建民.阿司匹林与糖尿病患者玻璃体出血以及玻璃体切割术疗效的相关性研究[J].眼科新进展,2012,32(11):000.
[3]李艳 李筱荣 袁佳琴 潘斌.糖尿病大鼠视网膜中VEGF、PEDF的表达与血-视网膜屏障损伤[J].眼科新进展,2013,33(1):000.
[4]李朝晖 崔治华 胡晓英 孟丽珠 张敬维.糖尿病视网膜病变激光面积与疗效的分析[J].眼科新进展,2013,33(2):000.
[5]冯冬梅 朱鸿 施彩虹.CXC趋化因子及其受体在糖尿病视网膜病变中的作用[J].眼科新进展,2013,33(6):000.
[6]牛淑玲.糖尿病视网膜病变患者HbAlc、FPG与血小板参数的变化及危险因素分析[J].眼科新进展,2013,33(7):000.
[7]毕春潮 王睿 王建洲 雷春灵 董晓娟 王小莉 薛晓辉.Ad-PEDF对糖尿病视网膜病变大鼠视网膜新生血管的抑制作用[J].眼科新进展,2013,33(8):000.
[8]杨萍 孙书明 李晓鹏.辛伐他汀对糖尿病视网膜病变和炎症因子的影响[J].眼科新进展,2013,33(8):000.
[9]罗文婷 孙大卫.血管黏附蛋白-1在眼科疾病中的研究进展[J].眼科新进展,2013,33(8):000.
[10]李小璐 马雅玲.糖尿病视网膜病变大鼠视网膜VEGF和PEDF的动态表达[J].眼科新进展,2013,33(9):000.

备注/Memo

备注/Memo:
国家自然科学基金项目（编号：81641057）；辽宁省科技厅计划项目（编号：201602287）；辽宁省大学生创新创业课题（编号：2015101600）；锦州医科大学校长基金（编号：XZJJ20130213）
更新日期/Last Update: 2018-05-09